| 70748-339-01 |
70748-339 |
HUMAN PRESCRIPTION DRUG |
DOXORUBICIN HYDROCHLORIDE |
DOXORUBICIN HYDROCHLORIDE |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20240826 |
N/A |
ANDA |
ANDA215178 |
Lupin Pharmaceuticals, Inc. |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (70748-339-01) / 10 mL in 1 VIAL, SINGLE-USE |
| 70748-340-01 |
70748-340 |
HUMAN PRESCRIPTION DRUG |
DOXORUBICIN HYDROCHLORIDE |
DOXORUBICIN HYDROCHLORIDE |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20240826 |
N/A |
ANDA |
ANDA215178 |
Lupin Pharmaceuticals, Inc. |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (70748-340-01) / 25 mL in 1 VIAL, SINGLE-USE |
| 68001-629-26 |
68001-629 |
HUMAN PRESCRIPTION DRUG |
DOXORUBICIN HYDROCHLORIDE |
DOXORUBICIN HYDROCHLORIDE |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20250107 |
N/A |
ANDA |
ANDA215178 |
BluePoint Laboratories |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (68001-629-26) / 25 mL in 1 VIAL, SINGLE-USE |
| 68001-629-36 |
68001-629 |
HUMAN PRESCRIPTION DRUG |
DOXORUBICIN HYDROCHLORIDE |
DOXORUBICIN HYDROCHLORIDE |
INJECTION, SUSPENSION, LIPOSOMAL |
INTRAVENOUS |
20250107 |
N/A |
ANDA |
ANDA215178 |
BluePoint Laboratories |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (68001-629-36) / 10 mL in 1 VIAL, SINGLE-USE |